Mr Ian Johnston

Experts / Mr Ian Johnston

Environment and science correspondent,Comment editor @thescotsman and @edinburghpaper, interests include environment, politics, history, cycling, guitar, chess

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Cardiology

Podcasts

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

Cardiology

Podcasts

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

By Dr Robert Hungerford

Podcasts

Cardiology

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

By Dr Robert Hungerford

Podcasts

Cardiology

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

By Dr Robert Hungerford

Videos

Cardiology, Drugs and devices

Remember me

Forgot your password?

Sign up for a free Healthed account

You are one step away from accessing the latest educational resources from Healthed.

Extra Details

Title

AHPRA number *

AHPRA Lookup

confirm-checkbox

Profession list *

Other Profession *

I have read and agree to Healthed's Terms & Conditions and Privacy Policy, and confirm that I am a healthcare professional.

Already a member? Sign in here

Back to login screen

Mr Ian Johnston

More from this expert

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Save 50% on all seminars. Hurry, sale ends Dec 31!

You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!

Mr Ian Johnston

More from this expert

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

An update on heart failure in general practice

Dr Robert Hungerford describes when heart failure should be suspected, how it can be assessed and diagnosed.

Cardiovascular risk assessment in lipid management

Dr Robert Hungerford discusses the latest evidence-based recommendation to lower LDL-C targets even further.

Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Save 50% on all seminars. Hurry, sale ends Dec 31!

You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!